Health-related quality-of-life results for pembrolizumab versus placebo after complete resection of high-risk stage III melanoma from the EORTC 1325-MG/Keynote 054 trial: An international randomized double-blind phase III trial

Annals of Oncology ◽

10.1093/annonc/mdy289.034 ◽

2018 ◽

Vol 29 ◽

pp. viii456 ◽

Cited By ~ 4

Author(s):

C. Coens ◽

A. Bottomley ◽

C.U. Blank ◽

M. Mandala ◽

G.V. Long ◽

...

Keyword(s):

Quality Of Life ◽

Complete Resection ◽

Phase Iii ◽

Health Related Quality ◽

Double Blind ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related ◽

Stage Iii Melanoma

Download Full-text

Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(17)30015-3 ◽

2017 ◽

Vol 18 (3) ◽

pp. 393-403 ◽

Cited By ~ 56

Author(s):

Corneel Coens ◽

Stefan Suciu ◽

Vanna Chiarion-Sileni ◽

Jean-Jacques Grob ◽

Reinhard Dummer ◽

...

Keyword(s):

Quality Of Life ◽

Complete Resection ◽

Health Related Quality ◽

Phase 3 ◽

Double Blind ◽

Related Quality ◽

Health Related ◽

Stage Iii Melanoma ◽

Secondary Outcomes

Download Full-text

PDB63 Improvements in Health-Related Quality of Life in Acromegaly With Pasireotide LAR and Octreotide LAR: Results From a Large, Randomized, Double-Blind Phase III Trial

Value in Health ◽

10.1016/j.jval.2012.08.1706 ◽

2012 ◽

Vol 15 (7) ◽

pp. A505 ◽

Cited By ~ 2

Author(s):

X. Badia ◽

A. Forsythe ◽

L.M. Nelson ◽

T.M. Coles ◽

L.D. Mcleod ◽

...

Keyword(s):

Quality Of Life ◽

Phase Iii ◽

Health Related Quality ◽

Double Blind ◽

Phase Iii Trial ◽

Octreotide Lar ◽

Related Quality ◽

Health Related

Download Full-text

Faculty Opinions recommendation of Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969674.793470152 ◽

2013 ◽

Author(s):

Christopher Steer

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related

Download Full-text

Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomised phase III trial

European Journal of Cancer ◽

10.1016/j.ejca.2011.05.017 ◽

2012 ◽

Vol 48 (3) ◽

pp. 311-323 ◽

Cited By ~ 30

Author(s):

D. Cella ◽

A.S. Pickard ◽

M.S. Duh ◽

A. Guerin ◽

N. Mishagina ◽

...

Keyword(s):

Quality Of Life ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related

Download Full-text

861 EFFECTS OF SUNITINIB VERSUS INTERFERON-ALFA IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): RESULTS FROM A RANDOMIZED MULTINATIONAL PHASE III TRIAL

European Urology Supplements ◽

10.1016/s1569-9056(07)60856-2 ◽

2007 ◽

Vol 6 (2) ◽

pp. 238 ◽

Cited By ~ 3

Author(s):

D. Cella ◽

J.Z. Li ◽

J.C. Cappelleri ◽

A. Bushmakin ◽

S.T. Kim ◽

...

Keyword(s):

Quality Of Life ◽

Renal Cell Carcinoma ◽

Renal Cell ◽

Interferon Alfa ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related

Download Full-text

QLIF-25. EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL

Neuro-Oncology ◽

10.1093/neuonc/nox168.834 ◽

2017 ◽

Vol 19 (suppl_6) ◽

pp. vi206-vi206

Author(s):

Martin J B Taphoorn ◽

Linda Dirven ◽

Sophie Taillibert ◽

Jerôme Honnorat ◽

Thomas Chen ◽

...

Keyword(s):

Quality Of Life ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Tumor Treating Fields ◽

Related Quality ◽

Health Related ◽

Newly Diagnosed Glioblastoma

Download Full-text

1108 POSTER Health-related quality of life (HRQOL) and kidney cancer-related symptoms in patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib versus interferon (IFN)-alfa: results for European and US subsample analyses in a randomized, multinational phase III trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)70627-4 ◽

2007 ◽

Vol 5 (4) ◽

pp. 144

Author(s):

D. Cella ◽

J.Z. Li ◽

A.G. Bushmakin ◽

J.C. Cappelleri ◽

S.T. Kim ◽

...

Keyword(s):

Quality Of Life ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related

Download Full-text

Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial

PLoS ONE ◽

10.1371/journal.pone.0157067 ◽

2016 ◽

Vol 11 (6) ◽

pp. e0157067 ◽

Cited By ~ 8

Author(s):

Zeinab Hamidou ◽

Benoist Chibaudel ◽

Mohamed Hebbar ◽

Marine Hug de Larauze ◽

Thierry André ◽

...

Keyword(s):

Quality Of Life ◽

Colorectal Cancer ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Life Score ◽

Related Quality ◽

Health Related ◽

Dose Dense

Download Full-text

Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomized phase III trial.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.9096 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 9096-9096 ◽

Cited By ~ 2

Author(s):

A. S. Pickard ◽

D. Cella ◽

M. S. Duh ◽

A. Guerin ◽

N. Mishagina ◽

...

Keyword(s):

Quality Of Life ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Phase Iii ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related

Download Full-text

Impact of imatinib rechallenge on health-related quality of life in patients with TKI-refractory gastrointestinal stromal tumours: Sub-analysis of the placebo-controlled, randomised phase III trial (RIGHT)

European Journal of Cancer ◽

10.1016/j.ejca.2015.10.071 ◽

2016 ◽

Vol 52 ◽

pp. 201-208 ◽

Cited By ~ 4

Author(s):

Changhoon Yoo ◽

Min-Hee Ryu ◽

Byung-Ho Nam ◽

Baek-Yeol Ryoo ◽

George D. Demetri ◽

...

Keyword(s):

Quality Of Life ◽

Phase Iii ◽

Health Related Quality ◽

Gastrointestinal Stromal Tumours ◽

Phase Iii Trial ◽

Related Quality ◽

Health Related

Download Full-text